PMV Pharmaceuticals Inc. (PMVP)
1.11
-0.04 (-3.48%)
At close: Mar 28, 2025, 3:59 PM
1.11
0.00%
After-hours: Mar 28, 2025, 04:05 PM EDT
-3.48% (1D)
| Bid | 1.09 |
| Market Cap | 57.65M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -59.12M |
| EPS (ttm) | -1.13 |
| PE Ratio (ttm) | -0.98 |
| Forward PE | -0.84 |
| Analyst | Buy |
| Ask | 1.11 |
| Volume | 34,062 |
| Avg. Volume (20D) | 130,320 |
| Open | 1.15 |
| Previous Close | 1.15 |
| Day's Range | 1.11 - 1.15 |
| 52-Week Range | 1.11 - 2.26 |
| Beta | 1.45 |
About PMVP
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well a...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 25, 2020
Employees 47
Stock Exchange NASDAQ
Ticker Symbol PMVP
Website https://www.pmvpharma.com
Analyst Forecast
According to 3 analyst ratings, the average rating for PMVP stock is "Buy." The 12-month stock price forecast is $5, which is an increase of 350.45% from the latest price.
Stock Forecasts